ABOUT MELOSO BAR

The introduction of nicotinamide for a nicotine alternative in e-cigarette and smokeless items signifies a major regulatory obstacle to the FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to act as a sedative at substantial dosages6. The claims produced by Nicotine River, ECBlend, along with other suppliers that their